Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.5132
+0.0032 (0.63%)
Sep 15, 2026, 2:41 PM EDT - Market open
Pasithea Therapeutics Employees
Pasithea Therapeutics had 5 employees as of December 31, 2025. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$4,258,324
Market Cap
17.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | 1 | 25.00% | 5 | 0 |
| Dec 31, 2024 | 4 | -4 | -50.00% | 4 | 0 |
| Dec 31, 2023 | 8 | -7 | -46.67% | 8 | 0 |
| Dec 31, 2022 | 15 | 10 | 200.00% | 15 | 0 |
| Dec 31, 2021 | 5 | 2 | 66.67% | 3 | 2 |
| Jun 30, 2021 | 3 | - | - | 1 | 2 |
| Mar 31, 2021 | 3 | - | - | 1 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cerenome | 28 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| BioCardia | 21 |
| Lipocine | 14 |
| BioVie | 13 |
| NewcelX | 12 |
| Allarity Therapeutics | 8 |
KTTA News
- 1 day ago - Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference - GlobeNewsWire
- 6 days ago - Pasithea Therapeutics Transcript: AGM 2026 - Transcripts
- 6 days ago - Pasithea Therapeutics Slides: Corporate presentation - Filings
- 11 days ago - Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences - GlobeNewsWire
- 4 weeks ago - Pasithea Therapeutics Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Pasithea Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Pasithea Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Pasithea Therapeutics Proxy statement: Proxy filing - Filings